logo
Login

AARTI DRUGS LTD. (AARTIDRUGS) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into manufacturing and selling Active Pharmaceutical Ingredients (API's), Pharma Intermediates, Specialty Chemicals as well as Formulations.[1]It is exporting its API's and Speciali…

AARTIDRUGSUpdated 31 Aug 2026, 13:01

Aarti Drugs Ltd.

Market Cap

₹3,781Cr.

Current Price

₹414

High / Low

₹535/319

Stock P/E

21.9

ROE12.7%
ROCE11.6%
Book Value₹154
Face Value₹10.0
Dividend Yield0.48%

About

Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into manufacturing and selling Active Pharmaceutical Ingredients (API's), Pharma Intermediates, Specialty Chemicals as well as Formulations.[1]It is exporting its API's and Speciality chemicals to over 100 countries across the globe.[2]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1031099311711010496115117104118118
Inventory Days778710113286107125120102107106102
Days Payable7585911258611094103899697104
Cash Conversion Cycle105110103124109101127133130115127116
Working Capital Days132126334660836873797980
ROCE %21%18%17%17%17%20%33%21%15%14%14%12%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 31 August 2026 at 13:01

Designed & Shipped by Harshit Bansal